Joe rounds out our stellar management team with his strong background in oncology managed markets
Hudson, Ohio (PRWEB) January 19, 2010
onPoint Oncology, LLC., a full service healthcare data solutions and reimbursement analytics firm, is proud to announce that Joe Baffone, an 18-year oncology executive with Sanofi-Aventis has joined onPoint Oncology LLC. "Joe rounds out our stellar management team with his strong background in oncology managed markets," said Tracy Lewis (President of onPoint), "We now have every facet in the oncology business covered. This range of expertise brings great value to our rapidly growing list of clients who need ground-breaking and creative project leadership in this dynamic environment."
"onPoint Oncology’s existing work to create novel products for their clients was my primary motivation," said Joe Baffone, "along with the opportunity to be part of the development, implementation and execution of innovative solutions in this dynamic market."
Joe Baffone has joined onPoint from Sanofi Aventis, where his background is steeped in sales, sales training, sales leadership, reimbursement, account management, national accounts. Particularly appealing for onPoint was his recent body of work with and on oncology managed market strategy. Mr. Baffone conceptualized, developed and led a non-traditional account management team responsible for working with commercial payers and oncology providers. His responsibilities included areas such as pathways, contracting and commercialization of new products.
"He shares onPoint's passion for making a difference for the cancer patient and believes a collaborative approach among stakeholders is necessary to provide efficient and effective payer payment throughout the cancer market" said Bobbi Buell, reimbursement evangelist and principal in onPoint.
onPoint Oncology provides solutions and cutting-edge educational programs for issues affecting today’s challenged oncology practice. For their pharmaceutical manufacturer partners, onPoint Oncology specializes in speeding reimbursement and assuring that both new and established drugs are paid appropriately. They also offer innovative, value-based data solutions for several major oncology brand teams.
# # #